CHNC China Infrastructure Construct

CHNC Announces a New Member of Its Board of Directors

CHNC Announces a New Member of Its Board of Directors

HOUSTON, TX, Oct. 20, 2021 (GLOBE NEWSWIRE) -- via -- China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces that Elizabeth Hernandez, a member of its board of directors and its Chief Operating Officer, has left the Company (July 28th, 2021) and is no longer serving in these capacities. The Company is not aware of her future plans.

Nevertheless, this position will not remain empty and has been filled with one of the team’s responsible architects of International Strategic Alliances. “We are pleased to announce that we will be welcoming one of our very best as a member of our Board of Directors, Anne Marie Graham, Attorney at Law and CHNC’s Director of International Markets,” says Henry Levinski, CHNC’s Treasurer. 

Since her arrival at CHNC she has contributed to the Company her years of business acumen, as well as her experience as a corporate lawyer, developing partnerships with international academic institutions.

Previous to her new responsibilities, she was in charge of the well-known Cannabis World Journals magazine. Ms. Graham was instrumental in achieving successful alliances with ICESI University in Cali, as well as the negotiations with a variety of Latin American academic institutions to expand the reach of CHNC all over the world. As a result, she received the title of CLO.

As an attorney at law, she has made sure the company is at the top of the game in legal developments within the industry and has kept our audiences informed of the regulatory frameworks that are sometimes so hard to manage within this industry. Her vast background in public speaking, as attested with her numerous victories in contests such as the III Iberoamerican Tax Moot Court held by the University of Florida in Gainesville, made her a keen mediator in every new deal we have struck, and her legal background has given us the advantage in each contract we have drafted. The lion’s share of our growth as a company is due to her excellent management skills which turned our expanding ranks into a well-oiled machine.

“As one of the Directors of the company I have witnessed production and execution and now I am eager to fulfill my duties as a Member of the Board moving CHNC forward to higher profitability while continuing to expand our grasp in new and exciting markets,” states Anne Marie Graham.

We wish her the very best in this new professional turn in her career and having had the pleasure to work alongside her, we now are excited to see the great new lengths this company will reach with the help of her guidance in her new responsibilities.

To learn more visit: 

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

For more information contact us at:



817/528-2475 for English

214/733-0868 for Spanish



EN
20/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassific...

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CBIH is proud to announce that Brian Cuban, Esq., a distinguished attorney, best-selling author, mental health advocate, and esteemed member of our Advisory Board, has officially joined the Reclassification Team. Mr. Cuban will play a crucial role in representing CBIH at the upcoming DEA hearings on marijuana rescheduling. Brian Cuban, the younger brother of entrepreneur Mark Cuban, brings a unique combination of personal recovery experience and professional advocacy to ...

 PRESS RELEASE

Cannabis Bioscience International Holdings (CBIH) Announces Partnershi...

Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products HOUSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to announce a groundbreaking partnership with Stephen Gould, marking a monumental step forward in the manufacturing and distribution of CBIH’s advanced medical product line. This collaboration represents a shared commitment to excellence and innovation in the healthcare industry. Stephen Gould, a company with a remarkable presence...

 PRESS RELEASE

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Resche...

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing HOUSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (CBIH) continues its unwavering advocacy for cannabis as a legitimate medicine by formally petitioning to have Ms. Alexis Bortell, long-time cannabis advocate and patient, to serve as a witness in the upcoming DEA hearing on marijuana rescheduling. Alexis Bortell has been a leading voice in the fight for medical cannabis access since being diagnosed with intractable epilepsy at the age of seven. After enduring years...

 PRESS RELEASE

A Letter from the Desk of CBIH

A Letter from the Desk of CBIH HOUSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings CEO Dante Picazo Addresses Cannabis Reclassification and DEA Hearings Dear Community, On Monday, December 2, I had the honor of representing Cannabis Bioscience International Holdings (CBIH) at the DEA Hearing Docket No. 1362 and Hearing Docket No. 24-44, focused on the reclassification of cannabis. Being chosen to speak on behalf of not only our company but also medicine, science, and patients is a privilege and a profound responsibility. CBIH remains committed to activ...

 PRESS RELEASE

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hear...

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing HOUSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing on cannabis reclassification. Representing CBIH at this critical event in Arlington, Virginia, is Dante Picazo, the company’s esteemed Director and CEO, bringing years of expertise and leadership in the medical cannabis industry to Docket No. 1362, Hearing Docket No. 24-44. Mr. Picazo has presented a comprehensive 78-page statement that un...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch